Breaking News Instant updates and real-time market news.

BBBY

Bed Bath & Beyond

$21.50

0.27 (1.27%)

09:15
04/12/18
04/12
09:15
04/12/18
09:15

Bed Bath & Beyond downgraded to Underperform at Raymond James

BBBY Bed Bath & Beyond
$21.50

0.27 (1.27%)

04/12/18
JPMS
04/12/18
NO CHANGE
Target $16
JPMS
Underweight
Bed Bath & Beyond price target lowered to $16 from $18 at JPMorgan
JPMorgan analyst Christopher Horvers lowered his price target for Bed Bath & Beyond to $16 saying the company's negative comps in both Q4 ending and over the past two quarters are "particularly disappointing." As is the acceleration in gross margin declines, Horvers tells investors in a post-earnings research note. He believes the "pressure on the model" and competitive environment are evident in Bed Bath's 19% guide below the Street for 2018. The analyst keeps an Underweight rating on the shares.
04/12/18
WEDB
04/12/18
NO CHANGE
Target $18
WEDB
Neutral
Bed Bath & Beyond price target lowered to $18 from $23 at Wedbush
Wedbush analyst Seth Basham lowered his price target for Bed Bath & Beyond to $18 from $23 as he expects heavy investments to continue with payoff still unclear. The analyst reiterates a Neutral rating on the shares.
04/12/18
FBCO
04/12/18
NO CHANGE
Target $20
FBCO
Neutral
Bed Bath & Beyond price target lowered to $20 from $25 at Credit Suisse
Credit Suisse analyst Seth Sigman lowered his price target for Bed Bath & Beyond to $20 from $25 as the company's strategic plan is clear, but margin level leaves little room for error. The analyst reiterates a Neutral rating on the shares.
04/12/18
MSCO
04/12/18
NO CHANGE
Target $16
MSCO
Underweight
Bed Bath & Beyond price target lowered to $16 from $20 at Morgan Stanley
Morgan Stanley analyst Simeon Gutman said he is not convinced Bed Bath & Beyond's revenue will respond to the company's initiatives. Beyond a lift from the Babies R' Us bankruptcy, it is hard for him to see how the company can drive positive same-store sales without the aid of promotions, Gutman tells investors. He maintains an Underweight rating on Bed Bath shares and lowered his price target on the stock to $16 from $20.

TODAY'S FREE FLY STORIES

BAYRY

Bayer

$0.00

(0.00%)

15:19
11/20/18
11/20
15:19
11/20/18
15:19
Hot Stocks
Bayer granted FDA orphan designation for Hemophilia A treatment »

Bayer was granted FDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BILI

Bilibili

$13.68

0.65 (4.99%)

15:19
11/20/18
11/20
15:19
11/20/18
15:19
Options
Bilibili options imply 19.2% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
11/20/18
11/20
15:17
11/20/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XENE

Xenon Pharmaceuticals

$8.18

0.12 (1.49%)

15:16
11/20/18
11/20
15:16
11/20/18
15:16
Hot Stocks
Xenon granted orphan designation for alternating hemiplegia treatment »

Xenon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
11/20/18
11/20
15:16
11/20/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCG

Scana

$44.14

0.44 (1.01%)

, D

Dominion

$74.55

0.15 (0.20%)

15:12
11/20/18
11/20
15:12
11/20/18
15:12
Hot Stocks
Scana higher as Dominion offers alternate deal plan to South Carolina PSC »

According to a new filing…

SCG

Scana

$44.14

0.44 (1.01%)

D

Dominion

$74.55

0.15 (0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACHN

Achillion

$2.89

0.11 (3.96%)

15:10
11/20/18
11/20
15:10
11/20/18
15:10
Options
Second day of call buying in Achillion Pharma »

Second day of call buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NXRT

NexPoint Residential

$36.26

0.93 (2.63%)

15:06
11/20/18
11/20
15:06
11/20/18
15:06
Hot Stocks
NexPoint Residential VP Matt McGraner buys over $313K in company shares »

NexPoint Residential VP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMWYY

BMW

$0.00

(0.00%)

, DDAIF

Daimler AG

$0.00

(0.00%)

15:04
11/20/18
11/20
15:04
11/20/18
15:04
Periodicals
Trump plans talks with German car executives, Bloomberg says »

The White House has…

BMWYY

BMW

$0.00

(0.00%)

DDAIF

Daimler AG

$0.00

(0.00%)

VLKAY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPS

Gap

$24.91

-0.535 (-2.10%)

15:04
11/20/18
11/20
15:04
11/20/18
15:04
Options
Gap options imply 11.5% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Mar

D

Dominion

$74.65

0.25 (0.34%)

, SCG

Scana

$44.08

0.38 (0.87%)

15:01
11/20/18
11/20
15:01
11/20/18
15:01
Periodicals
Dominion proposes alternate plan for Scana deal, Bloomberg says »

Bloomberg cites an…

D

Dominion

$74.65

0.25 (0.34%)

SCG

Scana

$44.08

0.38 (0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USO

United States Oil Fund

$11.27

-0.865 (-7.13%)

15:00
11/20/18
11/20
15:00
11/20/18
15:00
Options
Active trading in US Oil Fund options as crude oil drops 7% »

Active trading in US Oil…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:00
11/20/18
11/20
15:00
11/20/18
15:00
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

HIMX

Himax

$4.05

-0.075 (-1.82%)

14:56
11/20/18
11/20
14:56
11/20/18
14:56
Downgrade
Himax rating change  »

Himax downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 04

    Dec

  • 05

    Dec

14:55
11/20/18
11/20
14:55
11/20/18
14:55
General news
U.S. Durable Goods Preview »

U.S. Durable Goods…

14:55
11/20/18
11/20
14:55
11/20/18
14:55
General news
U.S. Existing Home Sales Preview »

U.S. Existing Home Sales…

14:55
11/20/18
11/20
14:55
11/20/18
14:55
General news
U.S. Michigan Consumer Sentiment Preview »

U.S. Michigan Consumer…

14:55
11/20/18
11/20
14:55
11/20/18
14:55
General news
U.S. Leading Indicators Preview »

U.S. Leading Indicators…

FB

Facebook

$131.60

-0.02 (-0.02%)

14:53
11/20/18
11/20
14:53
11/20/18
14:53
Periodicals
Dashboard to track time wasted on Facebook starts roll out, Venture Beat says »

Facebook has confirmed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

HIMX

Himax

$4.05

-0.075 (-1.82%)

14:52
11/20/18
11/20
14:52
11/20/18
14:52
Downgrade
Himax rating change  »

Himax downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 04

    Dec

  • 05

    Dec

XRT

S&P Retail Index SPDR

$44.32

-1.2 (-2.64%)

14:50
11/20/18
11/20
14:50
11/20/18
14:50
Options
SPDR Retail Trust options are active ahead of Black Friday »

SPDR Retail Trust options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADSK

Autodesk

$122.41

-3.34 (-2.66%)

14:49
11/20/18
11/20
14:49
11/20/18
14:49
Options
Autodesk options imply 12.7% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 26

    Nov

  • 04

    Dec

EQT

EQT Corporation

$16.81

-0.25 (-1.47%)

14:45
11/20/18
11/20
14:45
11/20/18
14:45
Options
EQT Corporation call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCAU

Fiat Chrysler

$15.78

-0.635 (-3.87%)

14:35
11/20/18
11/20
14:35
11/20/18
14:35
Options
Fiat Chrysler put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLDX

Celldex

$0.31

-0.0002 (-0.06%)

14:32
11/20/18
11/20
14:32
11/20/18
14:32
Hot Stocks
Celldex announces launch of Chase Offers »

Cardlytics announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.